ArticleMolecular cancer2024

Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy.

Yumi Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.